Allergy Partners

Allergy Partners is a healthcare organization that concentrates on the diagnosis, treatment, and management of allergic conditions, asthma, and related immunologic disorders. Its core services include allergy testing—such as skin prick and blood analyses—and immunotherapy regimens, most notably allergy shots, which are administered to patients to reduce sensitivity to specific allergens. The organization serves both pediatric and adult populations across the United States, operating a series of outpatient clinics where physicians deliver these specialized services. By focusing exclusively on allergy and immunology care, Allergy Partners provides a targeted alternative to general medical practices, allowing it to develop deep expertise in areas such as allergen immunotherapy, diagnostic testing, and the management of complex allergic diseases. The ransomware attack reported on February 23 2020 underscored that the organization maintains multiple office locations, as the incident caused an eight‑day network outage that disrupted operations at several of its clinics and prevented staff from administering critical allergy shots, prompting an FBI investigation and a ransom demand of $1.75 million.

Although the prompt does not supply explicit figures for the organization’s total number of clinics, revenue, or employee count, the described scope of the cyber‑impact indicates a geographic footprint that extends beyond a single site, with offices in multiple communities affected simultaneously. Allergy Partners distinguishes itself within the healthcare sector by concentrating solely on allergy and immunology services, which positions it as a specialist provider rather than a broad‑spectrum medical group. This specialization enables the organization to align its clinical protocols with established guidelines and regulatory requirements, including compliance with HIPAA standards for protecting patient health information—a relevance highlighted by the ransomware event that targeted its IT infrastructure. Available descriptions characterize Allergy Partners as a physician‑owned network, meaning that the clinics are collectively owned and governed by the physicians who practice within them, rather than being subsidiaries of a larger corporate hospital system. This ownership model supports clinical autonomy while facilitating shared resources such as group purchasing, collective negotiation with insurers, and centralized information technology systems, which were the focal point of the 2020 attack.